Optimized timing of using infliximab in perianal fistulizing Crohn's disease

doi:10.3748/wjg.v26.i14.1554

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8733)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

536

WORD

187

HTML

5271

Figures (1-3)

791

Sum=6785

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

683

Download

1265

Sum=1948

Apr 14, 2020 (publication date) through Jul 29, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

World J Gastroenterol. Apr 14, 2020; 26(14): 1554-1563
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1554

Full Size Figure Download Figure

Figure 3 Therapeutic strategy of perianal fistulizing Crohn’s disease. MRI: Magnetic resonance imaging.

Citation: Sun XL, Chen SY, Tao SS, Qiao LC, Chen HJ, Yang BL. Optimized timing of using infliximab in perianal fistulizing Crohn's disease. World J Gastroenterol 2020; 26(14): 1554-1563
URL: https://www.wjgnet.com/1007-9327/full/v26/i14/1554.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i14.1554